Nam Sai Gon International Hospital
WebsiteOverview
A private international general hospital in Ho Chi Minh City, where oncology is organised as an oncology clinic led by doctors who worked for many years at Bệnh viện Chợ Rẫy (Cho Ray Hospital).
Its laboratory holds ISO 15189:2022 accreditation (announced on 10 April 2026) - one of the first hospitals in the southern region to meet this standard for diagnostic imaging and laboratory testing.
Cancer screening packages (breast, lung and others) are included in its general health check-up list.
Scale
Total bed numbers, and beds for oncology, have not been published in the sources checked.
Accreditation
ISO 15189:2022 for the laboratory (announced on 10 April 2026) - covering controls across the 3 stages before, during and after testing. JCI could not be verified.
Strengths and key treatments
Dr Vương Thị Nguyên Thảo (MSc, Level II specialist): more than 30 years of experience in oncology and internal medicine, Level II specialist in oncology in 2017, certificate in palliative care from the National Cancer Centre Singapore (2007); formerly Head of the Palliative Care Department at the Cancer Centre of Bệnh viện Chợ Rẫy (2015-2022); specialises in screening and medical treatment of gastrointestinal, hepatobiliary and urological cancers, and in palliative care.
Dr Lê Thị Thu Sương (Level II specialist): more than 25 years of experience, Level II specialist in oncology in 2015, formerly Deputy Head of the Oncology Department at Bệnh viện Chợ Rẫy (2011-2017); treats solid malignancies (breast, lung, stomach, colorectal, head and neck, gynaecological, skin, central nervous system, soft tissue) with chemotherapy, targeted therapy, immunotherapy and palliative care.
Oncologists
More than 30 years of experience in oncology/internal medicine; former Head of the Department of Palliative Care, Cho Ray Hospital Oncology Center (2015-2022).
More than 25 years of experience; former Deputy Head of the Department of Oncology at Cho Ray Hospital (2011-2017); medical treatment of solid malignancies.